Ledger.Open graph →
SEC Form D · filed April 27, 2023

Lapix Therapeutics Inc

Offering
$14.6M
Sold
$5.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Anas Fathallah · Boston, MAExec · DirectorJason Norris · Burlington, MADirectorJason Norris · Burlington, MADirectorAnas Fathallah · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗